JOUNCE THERAPEUTICS INC (JNCE)

US4811161011 - Common Stock

1.88  -0.05 (-2.59%)

After market: 1.92 +0.04 (+2.13%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
82.00M26.91M62.30M147.90M65.20M
Operating Expenses
134.24M117.96M107.50M95.10M96.50M
Research and Development
103.27M88.98M78.70M67.10M70.10M
Selling, General, and Administrative Expenses
30.97M28.98M28.80M27.90M26.40M
Operating Income
-52.24M-91.06M-45.10M52.80M-31.30M
Other Income/Expense
1.46M199.00K1.30M4.10M4.00M
Income Before Taxes
-50.78M-90.86M-43.80M56.90M-27.30M
Income Tax
135.00K15.00K0.000.000.00
Net Income
-50.92M-90.87M-43.80M56.80M-27.40M
EBITDA
-50.16M-88.23M-41.70M56.70M-27.50M
 
Per Share Data
EPS Diluted Total Ops
-0.99-1.82-1.241.66-0.84
Non GAAP EPS
-0.99-1.84-1.471.63-0.83
 
Statistics
Profit Margin
-62.10%-337.73%-70.30%38.40%-42.02%
Operating Profit Margin
-63.71%-338.41%-72.39%35.70%-48.01%

All data in USD

Charts